Summary
- Current Price
- As of today, DGX price is $244.39, up +1.28% on
- Current Price All-Time High
- DGX price is currently -0.53% below its historical high of $245.68 set on
- Market Cap
- DGX current market cap is $27B, up +31.09% over the past 365 days
- PE Ratio
- DGX current PE ratio is 25.92
- Revenue
- DGX current annual revenue is $11.04B, up +11.78% year-over-year
- Next Earnings
- The next earnings release for DGX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Quest Diagnostics Incorporated |
| Ticker | NYSE: DGX |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | questdiagnostics.com |
| Employees | 55,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $244.39 | |
| Price, 1D Change | +1.28% | |
| Market Cap | $27B | |
| TTM Dividend Yield | 1.36% | |
| PE Ratio | 25.92 | |
| Beta | -0.16 | |
| Revenue | $11.04B | |
| Revenue, 1Y Change | +11.78% | |
| EPS | $8.74 | |
| EPS, 1Y Change | +14.09% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.86 | |
| Next Ex-Dividend | $0.86 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $8.74 | |
| EPS Estimate | $11.19 | N/A |
| EPS Est. Change | +28.00% | N/A |
| Revenue | $11.04B | |
| Revenue Estimate | $12.01B | N/A |
| Revenue Est. Change | +8.81% | N/A |
| Current Price | $244.39 | |
| Price Target | $250.00 | - |
| Price Tgt. Change | +2.30% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.90 | $7.66 | -13.89% | |
| $9.81 | $8.74 | -10.88% | |
| $11.19 | N/A | +28.00% | |
| $12.06 | N/A | +37.91% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.83B | $9.87B | +0.41% | |
| $10.99B | $11.04B | +0.39% | |
| $12.01B | N/A | +8.81% | |
| $12.57B | N/A | +13.91% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +33.02% | |
| Price, 3Y | +83.90% | |
| Market Cap, 1Y | +31.09% | |
| Market Cap, 3Y | +81.23% | |
| Revenue, 1Y | +11.78% | |
| Revenue, 3Y | +11.66% | |
| EPS, 1Y | +14.09% | |
| EPS, 3Y | +9.53% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $244.39 | |
| SMA 200 | $198.18 | |
| SMA 50 | $219.31 | |
| EMA 200 | $201.53 | |
| EMA 50 | $222.71 | |
| MACD | $6.31 | |
| Beta | -0.16 | |
| ATR | $5.41 | |
| 14-Day RSI | 74.65 | |
| 10-Day Volatility | 14.87% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.86 | |
| Upcoming | $0.86 | |
| Dividend Yield | 1.29% | |
| Total Dividend | $3.15 | |
| $353.00M | ||
| 33.88% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $11.04B | |
| EPS | $8.74 | |
| Gross Profit | $3.52B | |
| Gross Margin | 31.93% | |
| Operating Income | $1.60B | |
| Operating Margin | 14.53% | |
| Net Income | $1.04B | |
| Net Margin | 9.44% | |
| EBITDA | $2.17B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.89 | |
| 1.04 | ||
| 0.96 | ||
| - | ||
| 7 | ||
| 3.69 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 25.92 | |
| 2.33 | ||
| 3.59 | ||
| 14.46 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $7.17B | |
| $420.00M | ||
| $16.23B | ||
| $2.38B | ||
| $8.94B | ||
| $2.28B | ||
| Total Debt | $6.38B | |
| $678.00M | ||
| $1.60B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $10.05B | ||
| $1.92B | ||
| $7.51B | ||
| $0.00 | ||
| $570.00M | ||
| $0.00 | ||
| $314.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.89B | ||
| -$631.00M | ||
| -$1.39B | ||
| Capex | $527.00M | |
| $1.36B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| UBS | → | |
| Truist Securities | → | |
| Mizuho | → | |
| Barclays | → | |
| Baird | → | |
| Baird | → | |
| UBS | → | |
| Truist Securities | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with DGX
FAQ
- What is the ticker symbol for Quest Diagnostics Incorporated?
- The ticker symbol for Quest Diagnostics Incorporated is NYSE:DGX
- Does Quest Diagnostics Incorporated pay dividends?
- Yes, Quest Diagnostics Incorporated pays dividends. The last payment was $0.86, with an ex-dividend date on July 8, 2026
- What sector is Quest Diagnostics Incorporated in?
- Quest Diagnostics Incorporated is in the Healthcare sector
- What industry is Quest Diagnostics Incorporated in?
- Quest Diagnostics Incorporated is in the Diagnostics & Research industry
- What country is Quest Diagnostics Incorporated based in?
- Quest Diagnostics Incorporated is headquartered in United States
- When did Quest Diagnostics Incorporated go public?
- Quest Diagnostics Incorporated initial public offering (IPO) was on December 17, 1996
- Is Quest Diagnostics Incorporated in the S&P 500?
- Yes, Quest Diagnostics Incorporated is included in the S&P 500 index
- Is Quest Diagnostics Incorporated in the NASDAQ 100?
- No, Quest Diagnostics Incorporated is not included in the NASDAQ 100 index
- Is Quest Diagnostics Incorporated in the Dow Jones?
- No, Quest Diagnostics Incorporated is not included in the Dow Jones index
- When was Quest Diagnostics Incorporated last earnings report?
- Quest Diagnostics Incorporated's most recent earnings report was on July 23, 2026
- When does Quest Diagnostics Incorporated report earnings?
- The next expected earnings date for Quest Diagnostics Incorporated is October 20, 2026
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207926000005/0001022079-26-000005-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx
